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1. DID FLUOROPHORE CHARACTERIZATION 
 
To assess the quenching behavior of DiD, labeled 1 mg/mL POPC vesicle preparations with 
varying molar percentages of DiD: 0.5, 1, 2, 3, 5, 7.5, 10, and 12.5 mol%, and used buffers at 
pH from 5.1-7.5 (the pH range relevant for endosomal escape; see SI). Vesicle preparations 
were mixed 1:1 with citrate-HEPES buffer and measured in a Synergy HT plate reader to 
monitor total brightness relative to fluorophore content (BioTek, monochromator excitation 
644 nm, emission 670 nm, background correction 500 nm, average of 10 reads). 
 
The total fluorescence of the vesicle samples rose from 0.5% to 3% DiD, then dropped to a 
lower intensity plateau for concentrations 5% -12.5% with little fluorescence gain from 
fluorophore added past 5% (Figure S1A). Importantly, the total fluorescence in the cuvette 
was lower for the higher-DiD concentrations, where the sample is quenched, than for the 
dequenched samples, even when the total amount of fluorophore was an order of 
magnitude larger. We conclude that if the molar percentage of DiD is above roughly 5%, 
then variation in total fluorophore amount due to heterogeneity in vesicle or virion sizes will 
be small in comparison with the large intensity shifts that would occur if the dye 
dequenches due to dilution upon fusion with a target membrane (Figure S1). However, 
intensities in post-fusion states could vary more widely based on the initial fluorophore 
amount. 
 
When measurements were normalized according to total fluorophore concentration (as 
determined by absorbance at 645 nm), a linear decrease in fluorophore brightness from 
0.5% to 5% was visible, with a dark plateau at concentrations 5% and above, and a total 
intensity difference of roughly 10-fold between 5% and 0.5% DiD (Figure S1B). The effect of 
pH was minimal compared to that of concentration (Figure S1). In the context of a fusion 
sample, fusion between a 5% DiD vesicle and a virion of similar size, both smaller than the 
point-spread function of the cryo-FM, would result in a roughly 10-fold increase in 
fluorescence at that location (Figure S1B). Other size relationships would be dependent 
upon both the dilution factor of the DiD upon fusion according to target surface area, and 
distribution of fluorescence intensity over the imaging area of the fused membranes. 
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Figure S1. Fluorophore quenching at room temperature. A: Fluorescence intensity of 
vesicles with varying lipid concentration. Even as the total fluorophore concentration of the 
sample increases, autoquenching at 5% DiD results in lower total fluorescence intensity. B: 
Results from A, normalized to equal fluorophore concentration (varying total lipid 
concentration). Autoquenching is linear from 0.5-5% DiD, at which point the dye is fully 
quenched. 
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2. FUSION ASSAY FOR VIRUS-LIKE PARTICLES AND 5% DID VESICLES 
 
Fusion assays were performed to confirm VLP function and DiD dequenching signal at room 
temperature under fusion conditions. Briefly, 80 µL fusion mix was prepared using 50 µM 
target membrane lipid (2.5 µM DiD, see methods above), pH 7.5 HEPES-citrate buffer, and a 
volume of VLPs corresponding to 0.014 mg accessible protein. The mix was prepared in the 
wells of a 96-well plate, which was then loaded immediately into a plate reader (BioTek, 
Synergy H1). After a five-minute incubation at 37 C, the mix was acidified to pH 5.1 by 
injection of 45 µL of pH 3 HEPES-citrate buffer. The plate was shaken for 15 s to mix, 
followed by reads every 30 s for 20 minutes  (620/40 excitation, 680/30 emission, gain 35).  
Finally, the plate was removed and 0.5% Triton X-100 was added to the wells with pipetting 
to lyse the vesicles and VLPs. 
 
Assays were normalized for total fluorophore concentration by subtracting the pre-
acidification intensity and dividing by the intensity following lysis with 0.5% Triton X-100, 
which corresponds to complete dequenching. The acidification results in hemifusion 
between VLPs and liposomes, dequenching the dye as it is distributed into a larger lipid pool 
(progression of hemifusion to fusion is typically assumed but not directly monitored by 
dequenching of a single intercalated dye). The VLPs displayed robust and rapid achievement 
of hemifusion, reaching a fluorescence intensity plateau by 3 minutes post-acidification 
(Figure S2). 
 
 
 
 
 
 
 
 
Figure S2. Kinetic assay for hemifusion between influenza VLPs and 5% DiD liposomes. 
Fusion is stimulated by acidification to pH 5.1 at time = 0 s. 
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3. MATERIALS AND METHODS 
 
 
Fluorophore Stock Preparation 
 
R18 
Octadecyl Rhodamine B Chloride (R18, Thermo Fisher Scientific) was solubilized in 100% 
ethanol at roughly 10 mg/mL and stored at -80 C in glass vials sealed with Teflon tape for up 
to 1 month.  Exact concentration was determined by measuring absorbance in methanol, 
using the manufacturer’s extinction coefficient under these conditions. 
 
DiD 
DiIC18(5) solid (1,1'-Dioctadecyl-3,3,3',3'-Tetramethylindodicarbocyanine, 4-
Chlorobenzenesulfonate Salt, Thermo Fisher Scientific) was solubilized in 100% ethanol at 
roughly 5 mM and stored at -20 C in glass vials sealed with Teflon tape.  Exact concentration 
was determined by measuring absorbance in methanol (1 µL stock in 1.5 mL methanol), 
using the manufacturer’s extinction coefficient under these conditions. 
 
 
Vesicle Preparation 
 
POPC vesicles (Figures 1, S1) 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (Avanti Lipids) was dissolved in 
chloroform at 1 mg/mL concentration, then dried into a thin film in a round-bottom flask by 
evaporation using nitrogen gas.  This thin film rested overnight in a room-temperature 
dessicator.  Following evaporation, the POPC film was incubated in TNE buffer (50 mM Tris-
HCL pH 7.4, 100 mM NaCl, 0.1 mM EDTA) for 30 minutes at 4 C, then subjected to 7 cycles of 
freeze/thaw by alternating baths in an acetone/dry ice mixture and warm water.  The 
resulting lipid mixture was extruded for 21 passes through a membrane with a pore size 50-
200 nm depending upon the experiment (Avanti Lipids).  Average vesicle size and quality 
were confirmed by dynamic light scattering (DLS, see below). 
 
For Figure 1B, a mixture of 90% POPC / 10% POPS was used to decrease the clumping 
tendency of fully POPC vesicles, allowing better quantification of fluorescence intensity from 
separated vesicles on the EM grid. 
 
For DiD-labeled vesicles, the desired amount of fluorophore was incorporated into the 
chloroform/methanol mixture immediately prior to drying.  For R18-labeled vesicles, 
fluorophore was added to a glass autosampler vial with the extruded vesicle mixture and 
stirred for 30 minutes at room temperature.  Following labeling, aggregates and any 
unincorporated fluorophore were removed by passing vesicles through two consecutive 0.5 
mL 7K MWCO Pierce Zeba columns, following manufacturer’s protocols. 
 
Lipid vesicles for hemifusion experiments (Figures 2, S2). 
The lipid composition for these vesicles was adapted from Chlanda et al. 2016 (1).  A 
mixture of 47% POPC / 13% POPE / 35% cholesterol / 5% total ganglioside (Avanti Lipids) 
was prepared in a mixture of roughly 1 mg/mL in 2 parts chloroform / 1 part methanol; 5% 
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DiD was then added to this mixture prior to drying into a thin film overnight as above. Lipid 
vesicles were prepared by extrusion as above, using a buffer of 10 mM HEPES / 50 mM 
sodium citrate / 150 mM NaCl at pH 7.5 (2) and a 100 nm pore size.  Vesicle preparations 
were filtered by spin column as above. 
 
Vesicle concentration was estimated by DiD absorbance at 645 nm, assuming the 5% molar 
composition. 
 
Vesicle Size Assessment 
We prepared a comparison of vesicle sizes by DLS on a Zetasizer (Malvern Panalytical).  
Briefly, 100 µL of an unlabeled vesicle preparation (nominally 1 mg/mL) were measured for 
3 sets of 13 reads.  By this method, a 100 nm membrane produced vesicles with a mean 
diameter of 163.4 nm, with polydispersity of 0.144 (roughly 62 nm standard deviation). 
 
We then imaged this vesicle preparation on a cryo-EM grid.  A mixture of 1.5 µL vesicle 
preparation and 1.5 µL 10 nm gold fiducial marker was pipetted onto a C-Flat 2/2-300C EM 
grid, blotted in a Vitrobot (Mark 2, offset -4, 3 s blot time, >85% humidity, 15 C), and 
plunged into liquid ethane.  The resulting grid was imaged on a FEI Tecnai T12 microscope at 
12.5 A pixel size (9800x magnification), and vesicle sizes were measured using Amira 
software.  We found that the vesicles on the grid had a mean diameter of 88 ± 36 nm. 
 
We believe that this strong contrast in vesicle sizes is due to systematic biases in both 
instruments.  Briefly, DLS can over-estimate a vesicle diameter based on charge and 
hydration shells, and vesicle-vesicle association might also result in larger vesicle sizes 
without severely increased polydispersity if these interactions are transient.  On the other 
hand, we expect that large lipid vesicles are selected against during cryo-EM imaging, 
possibly due to increased contact with the blotting paper, greater exposure to the air-water 
interface, or preferential localization to areas of thick ice. 
 
 
Buffer Titration for pH Control 
 
We elected to use a HEPES-citrate dual-buffer system (10 mM HEPES / 50 mM sodium 
citrate / 150 mM NaCl) to control pH over a greater range, as in (2). pH is adjusted by 
addition of acidic buffer to the neutral buffer containing the sample, thus avoiding osmotic 
stress.  A titration curve was measured using a pH electrode, and was found to be linear 
within the pH range suitable for viral fusion experiments.  For these experiments, buffers at 
pH 7.5 and pH 3 were used.  The linear regression variables are an intercept of pH 6.4 (due 
to non-linearity outside the 10-50% range) and a slope of -0.036 pH units per percent acidic 
buffer (Figure S3). 
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Figure S3: Titration curve for citrate/HEPES/NaCl buffer.  The pH of neutral buffer can be 
specifically and reproducibly adjusted by addition of pH 3 buffer on a volume:volume basis. 
 
 
Virus-Like Particle (VLP) Preparation 
 
VLPs were prepared by transfection of influenza A proteins into HEK cells by adapting a 
previously described protocol (3).  PCAGGS plasmids for influenza A hemagglutinin (A/Hong 
Kong/1/68, HA), neuraminidase (A/Singapore/1/57, NA), and matrix proteins 1 (A/Hong 
Kong/1/68, M1) and 2 (A/Hong Kong/1/68, M2) were transfected into 1*106 HEK 293T cells 
in serum-free DMEM, with 2.2 µg HA, 2.2 µg NA, 4.4 µg M1, and 1.1 µg M2 DNA per plate 
and using 30 µL FuGene according to manufacturer’s instructions (Promega Corporation).  
Following transfection, a final concentration of 100 mU/µL exogenous NA (New England 
BioLabs, P0720S) was added to the plates to facilitate VLP release. 
 
After 48 hours, the VLPs were treated with trypsin to cleave the HA subunits (1).  Inhibited 
trypsin and cellular debris were removed by centrifugation at 900 xG for 10 minutes; VLPs 
were then harvested by centrifugation over a 32.5% sucrose cushion (SW40i rotor, 30k RPM, 
90 minutes).  VLP pellets were overlaid with citrate-HEPES buffer (above), allowed to rest 
overnight, and then resuspended gently with wide-mouthed pipet tips.  VLP preparations 
were cleaned of excess sucrose and soluble proteins by a 4-hour dialysis against citrate-
HEPES buffer using a 300 MWCO membrane, and gently concentrated in Microcon 100 
MWCO concentrators (EMD Millipore) using a rotor speed of no more than 900 xG.  VLPs 
prepared in this manner retained their mixed morphology (spheres and long filaments). 
 
VLP concentrations were approximated by monitoring accessible surface protein 
concentration using a Bio-Rad Protein Assay according to manufacturer’s instructions. 
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Cryo-EM/cryo-CLEM Grid Preparation 
 
For the quenched lipid-only grid (Figure 1B), fluorescent signals were of roughly even 
intensity across the grid, making fiducial-free alignments difficult as vesicles appeared 
identical to each other by both EM and FM.  We therefore used fluorescent fiducial markers 
to assist with high-precision correlation (4, 5).  Briefly, a purchased stock solution of 50 nm 
Tetraspec beads was sonicated for 5 minutes in a waterbath sonicator, and Protochip C-Flat 
grids (2/2, 300 mesh) were glow-discharged for 30 s at ~30 mA.  The tetraspec solution was 
diluted 1:50 in PBS, and 10 µL drops were incubated on the grids for 15 minutes.  Grids were 
back-side blotted, rinsed with two washes of deionized water, and allowed to dry prior to 
use. 
 
All cryo-EM/cryo-CLEM grids were frozen using the protocol from the Vesicle Size 
Assessment section above. 
 
For hemifusion grids, vesicles and VLPs were prepared as above, mixed, and incubated on 
ice at relative concentrations of 0.16 mg/mL accessible viral protein and 0.12 mM target 
membrane lipid for roughly 30 minutes. This provided ample time for VLPs and vesicles to 
adhere.  The tubes were then brought to room temperature and acidified to pH 5.1 for 60 s, 
followed by addition of 10 nm Protein A-coated gold fiducial markers (Cell Microscopy core, 
University Medical Center Utrecht).  The sample was then pipetted onto grids and frozen as 
above.  The total time between acidification and freezing was roughly 2.5 minutes, in 
keeping with the kinetics of the hemifusion plateau at room temperature. 
 
 
Cryo-Fluorescence Microscopy and Intensity Analysis 
 
Cryo-fluorescence microscopy was performed on Leica DM 1200 or DM6 FS cryo-CLEM 
microscopes running LAS X software and an OrcaFlash 4.0 V2 SCMOS camera (Hamamatsu 
Photonics).  Excitation intensities were adjusted as needed to avoid heavy oversaturation of 
the camera or devitrification from extended high-intensity illumination.  Typically, white 
transmitted light exposures were 80-100 ms, green channel imaging (480/40, 505, 527/30 
nm excitation, dichroic, emission filters, Tetraspecs) used 30% intensity with aperture 4 and 
exposure time of 0.8-1 s, red channel imaging (560/40, 585, 630/76 nm excitation, dichroic, 
emission filters, R18) used 17% intensity for 25 ms, and far-red channel imaging (620/60, 
660, 700/75 nm excitation, dichroic, emission filters, DiD) used 17% intensity with aperture 
4 and exposure times of 14 ms (hemifusion, Figure 2) or 150 ms (quenched vesicles, Figure 
1B).  Grids were focus-mapped using built-in software functions, and imaged in Z-stacks of 
10-12 slices and ~1 µm step sizes. 
 
Images of grid squares of interest were build using FIJI’s built-in Max Intensity projection 
algorithm (6, 7).  Full-grid maps for correlating on-the-fly were generated with the Fiji Stack 
Focuser plug-in. 
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Spot intensities were quantified in FIJI using the built-in 3D Surface Plot feature.  Briefly, the 
maximum peak intensity was recorded for each location, searching within the area of 
accuracy predicted by the correlation software and informed by visible chromatic offsets in 
the cryo-CLEM.  The local background was determined by the plateau nearest the peak in 
cases where multiple peaks were present; otherwise the local background was determined 
by averaging along the edge of the visualization box (extended to reach a plateau when 
necessary), using the same surface as the point of interest.  Points of interest that were near 
to contamination (ice) or areas of bright fluorescence without lipid/protein density (from 
fluorescent crystalline ice or suspected reflections) were avoided.  Reported peak intensities 
are of the background-subtracted maximum of the peak center. 
 
 
Cryo-Electron Microscopy and Correlation with Cryo-Fluorescence Microscopy 
 
Cryo-EM grids were imaged on an FEI Tecnai T12 microscope (hemifusion) or FEI Tecnai F20 
microscope (quenched DiD vesicles) running SerialEM.  Grids were mapped in full at 150X 
magnification, which was correlated with the white transmitted light cryo-FM map using 
SerialEM map registration functions (5). 
 
From this point, workflows followed different paths depending upon the goal of the 
experiment.  For quenched lipid grids where each vesicle’s intensity needed to be 
quantified, it was necessary to image at a magnification where each individual vesicle would 
be visible irrespective of fluorescence.  Therefore, grid squares of interest were imaged by a 
5x5 montage at 6000X magnification on the F20 microscope, and all alignment with cryo-
fluorescence images was performed during post-processing using Matlab cryo-CLEM 
correlation scripts (4). 
 
For hemifusion grids, we sought to both prepare maps for later correlation and to image 
bright and dim spots at higher magnification.  Grid squares of interest were mapped at 
1200X and aligned on-the-fly at the T12 microscope using SerialEM registration points based 
on visible grid square features and defects.  This rapid, fiducial-free approach provided an 
estimated 0.2-0.3 µm precision for the correlation, which was sufficient for the hemifusion 
sample.  (While higher magnification and alignment with fiducials would provide more 
precise correlation, this is time-consuming and was found to be unnecessary for this 
sample.)  The fluorescence map location was used to direct the stage to the expected 
position, at which point a 5000 X image was used to center the object closest to the 
expected position.  The image was then collected with 30,000 X magnification (0.37 nm pixel 
size, ~10 e/A2, -5 µm defocus). Matlab cryo-CLEM scripts were again used in post-processing 
to correlate all remaining points and confirm that the higher-magnification images truly 
corresponded to the fluorescence they were targeting.  Final correlation accuracy varied by 
square and ranged from roughly 60-200 nm. 
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